Bacteria in cancer initiation, promotion and progression

G El Tekle, WS Garrett - Nature Reviews Cancer, 2023 - nature.com
Cancer cells originate from a series of acquired genetic mutations that can drive their
uncontrolled cell proliferation and immune evasion. Environmental factors, including the …

Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy

L Yang, A Li, Y Wang, Y Zhang - Signal transduction and targeted …, 2023 - nature.com
Microorganisms, including bacteria, viruses, fungi, and other eukaryotes, play critical roles in
human health. An altered microbiome can be associated with complex diseases …

Microbiome analyses of blood and tissues suggest cancer diagnostic approach

GD Poore, E Kopylova, Q Zhu, C Carpenter… - Nature, 2020 - pmc.ncbi.nlm.nih.gov
Systematic characterization of the cancer microbiome provides a unique opportunity to
develop cancer diagnostics that exploit non-human, microbial-derived molecules in a major …

Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression

L Parhi, T Alon-Maimon, A Sol, D Nejman… - Nature …, 2020 - nature.com
Fusobacterium nucleatum is an oral anaerobe recently found to be prevalent in human
colorectal cancer (CRC) where it is associated with poor treatment outcome. In mice …

Cancer and the microbiome—influence of the commensal microbiota on cancer, immune responses, and immunotherapy

V Matson, CS Chervin, TF Gajewski - Gastroenterology, 2021 - Elsevier
The commensal microbiota has been implicated in the regulation of a diverse array of
physiological processes, both within the gastrointestinal tract and at distant tissue sites …

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

Y Gao, D Bi, R Xie, M Li, J Guo, H Liu, X Guo… - Signal transduction and …, 2021 - nature.com
Given that only a subset of patients with colorectal cancer (CRC) benefit from immune
checkpoint therapy, efforts are ongoing to identify markers that predict immunotherapeutic …

The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota

KD LaCourse, M Zepeda-Rivera, AG Kempchinsky… - Cell Reports, 2022 - cell.com
Fusobacterium nucleatum (Fn) is a dominant bacterial species in colorectal cancer (CRC)
tissue that is associated with cancer progression and poorer patient prognosis. Following a …

Fusobacterium nucleatum — symbiont, opportunist and oncobacterium

CA Brennan, WS Garrett - Nature Reviews Microbiology, 2019 - nature.com
Fusobacterium nucleatum has long been found to cause opportunistic infections and has
recently been implicated in colorectal cancer; however, it is a common member of the oral …

[HTML][HTML] The oral microbiota and its role in carcinogenesis

M Stasiewicz, TM Karpiński - Seminars in cancer biology, 2022 - Elsevier
Despite decades of research, cancer continues to be a major global health concern. In
recent years, the role played by microorganisms in the development and progression of …

The oral microbiome and cancer

M Irfan, RZR Delgado, J Frias-Lopez - Frontiers in immunology, 2020 - frontiersin.org
There is mounting evidence that members of the human microbiome are highly associated
with a wide variety of cancer types. Among oral cancers, oral squamous cell carcinoma …